Abiopharma

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088486 Size: 5 KB

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088484 Size: 5 KB

New Form 8-K - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088482 Size: 192 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - LIPELLA PHARMACEUTICALS INC. Filed: 2025-06-20 AccNo: 0001753926-25-000984 Size: 223 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-K - CYANOTECH CORP Filed: 2025-06-20 AccNo: 0001437749-25-020904 Size: 8 MB

New Form 144 - Ultragenyx Pharmaceutical Inc. Filed: 2025-06-20 AccNo: 0001950047-25-004490 Size: 4 KB

New Form 144 - Enliven Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001974158-25-000042 Size: 7 KB

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADAs Annual Scientific Sessions

New Form 8-K - COGNITION THERAPEUTICS INC Filed: 2025-06-20 AccNo: 0001104659-25-061142 Size: 193 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form SCHEDULE 13D/A - EYENOVIA, INC. Filed: 2025-06-20 AccNo: 0001829126-25-004618 Size: 26 KB

New Form SCHEDULE 13G - KNOW LABS, INC. Filed: 2025-06-20 AccNo: 0001654954-25-007258 Size: 9 KB

New Form 8-K - NORTECH SYSTEMS INC Filed: 2025-06-20 AccNo: 0001641172-25-015833 Size: 260 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 11-K - Ecovyst Inc. Filed: 2025-06-20 AccNo: 0001708035-25-000093 Size: 185 KB

New Form 6-K - GH Research PLC Filed: 2025-06-20 AccNo: 0001140361-25-023162 Size: 17 KB

New Form 144 - Oil-Dri Corp of America Filed: 2025-06-20 AccNo: 0001959173-25-004224 Size: 6 KB